| Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients (NCT02152943) | M.D. Anderson Cancer Center | 2014-07-17 |
| Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck (NCT02158234) | H. Lee Moffitt Cancer Center and Research Institute | 2014-07-16 |
| A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Liver Disease and in Age-, Weight- and Gender-matched Healthy Participants (NCT04722562) | Bayer | 2014-07-16 |
| Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis (NCT02165345) | Hoffmann-La Roche | 2014-07-16 |
| A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies (NCT02158858) | Constellation Pharmaceuticals | 2014-07-16 |
| A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma (NCT02157636) | Constellation Pharmaceuticals | 2014-07-15 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041) (NCT02180061) | Merck Sharp & Dohme LLC | 2014-07-15 |
| Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve (NCT02268032) | Laboratorios Andromaco S.A. | 2014-07-15 |
| Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease (NCT02195869) | Pharmacyclics LLC. | 2014-07-14 |
| Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy (NCT02161380) | Byron Lam | 2014-07-14 |
| Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States (NCT02184585) | GlaxoSmithKline | 2014-07-10 |
| A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT02123758) | Aragon Pharmaceuticals, Inc. | 2014-07-09 |
| Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt (NCT02143635) | Novartis Pharmaceuticals | 2014-07-07 |
| Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG (NCT01815346) | M.D. Anderson Cancer Center | 2014-07-06 |
| GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer (NCT02012192) | Medical University Innsbruck | 2014-07-04 |
| Phase 1a/1b BGB-290 for Advanced Solid Tumors. (NCT02361723) | BeiGene | 2014-07-03 |
| T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive (NCT02153905) | National Cancer Institute (NCI) | 2014-07-03 |
| Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency (NCT02181595) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2014-07-02 |
| Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma (NCT02133183) | National Cancer Institute (NCI) | 2014-07-02 |
| NeoVas Bioresorbable Coronary Scaffold First-in-Man Study (NCT02195414) | Lepu Medical Technology (Beijing) Co., Ltd. | 2014-07-01 |
| Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia (NCT01555697) | University of California, San Diego | 2014-07-01 |
| Cardioprotective Effects of GLP-1 and Their Mechanisms (NCT02128022) | Papworth Hospital NHS Foundation Trust | 2014-07-01 |
| A Phase 1, Randomized, Double-blind, Placebo-controlled Crossover Study of RG7314 on the Potential Regulation of Higher Brain Functions in Healthy Male Participants: Proof of Mechanism (NCT02205073) | Hoffmann-La Roche | 2014-07-01 |
| Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer (NCT01895790) | Johns Hopkins University | 2014-07-01 |
| Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication (NCT02184767) | Teva Branded Pharmaceutical Products R&D, Inc. | 2014-07-01 |
| A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants (NCT02197884) | Janssen Research & Development, LLC | 2014-07-01 |
| Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries (NCT02169362) | Arteriocyte, Inc. | 2014-07-01 |
| To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery (NCT02204813) | Washington University School of Medicine | 2014-07-01 |
| A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions (NCT02184429) | Pfizer | 2014-07-01 |
| Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers (NCT02185300) | ViiV Healthcare | 2014-07-01 |
| A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc Interval (NCT02165332) | Hoffmann-La Roche | 2014-07-01 |
| Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR (NCT02185066) | HK inno.N Corporation | 2014-07-01 |
| To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets (NCT02205151) | Boryung Pharmaceutical Co., Ltd | 2014-07-01 |
| Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers (NCT02191865) | Boehringer Ingelheim | 2014-07-01 |
| Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects. (NCT02187029) | Pfizer | 2014-07-01 |
| High Frequency Oscillations in Neurologic Disease (NCT02235792) | Mayo Clinic | 2014-07-01 |
| A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics (NCT02215499) | Concert Pharmaceuticals | 2014-07-01 |
| Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma (NCT02229981) | RedHill Biopharma Limited | 2014-07-01 |
| Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis (NCT01573923) | Alliancells Bioscience Corporation Limited | 2014-07-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects (NCT02207790) | Eisai Inc. | 2014-07-01 |
| Maraviroc as GVHD Prophylaxis in Transplant Recipients (NCT02167451) | Children's Hospital Medical Center, Cincinnati | 2014-07-01 |
| DNase Treatment for Dry Eyes (NCT02193490) | University of Illinois at Chicago | 2014-07-01 |
| Open Label Study of Tolerability, Pharmacokinetics and Pharmacodynamics of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif® and Avonex® in Healthy Volunteers (NCT02359877) | Biocad | 2014-07-01 |
| The Effect of Bowel Preparation on Perioperative Bleeding (NCT02493894) | Isfahan University of Medical Sciences | 2014-07-01 |
| PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients (NCT02214693) | Dong-A ST Co., Ltd. | 2014-07-01 |
| A Study to Assess the Drug-Drug Interaction Between VX-787 and Oseltamivir (NCT02262715) | Janssen Infectious Diseases BVBA | 2014-07-01 |
| Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects (NCT02232308) | Adil Bharucha | 2014-07-01 |
| Effectiveness and Safety of Autologous ADRC for Treatment of Degenerative Damage of Knee Articular Cartilage (NCT02219113) | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 2014-07-01 |
| 21 Day Cumulative Skin Irritation of RUT058-60 (NCT02198963) | Pulmatrix Inc. | 2014-07-01 |
| An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male Subjects (NCT02205905) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2014-07-01 |
| ALA-induced PpIX Fluorescence During Brain Tumor Resection (NCT02191488) | David W. Roberts | 2014-07-01 |
| A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374 (NCT02245828) | Novartis Pharmaceuticals | 2014-07-01 |
| Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge (NCT02237586) | Sanaria Inc. | 2014-07-01 |
| Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) (NCT02219633) | LEO Pharma | 2014-07-01 |
| Ultrasound Guided Local Anesthetic Block: Thoracolumbar Interfascial Plane (NCT02297191) | Medical University of South Carolina | 2014-07-01 |
| A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia (NCT02220712) | Otsuka Pharmaceutical Co., Ltd. | 2014-07-01 |
| A Study to Estimate the Effect of CYP3A4 Inhibitors (Itraconazole, Diltiazem or Verapamil) on the Pharmacokinetics of Single Dose PF- 00489791 in Healthy Volunteers (NCT02319148) | Pfizer | 2014-07-01 |
| Pharmacokinetics Properties of Single Oral Dosing of Lu AE58054 in Subjects With Hepatic Impairment (Mild and Moderate) and in Healthy Subjects (NCT02231450) | H. Lundbeck A/S | 2014-07-01 |
| A Safety, Tolerability, PD and PK Study in Healthy Adults (NCT02211625) | Trevena Inc. | 2014-07-01 |
| Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies (NCT02193958) | Fujifilm Pharmaceuticals U.S.A., Inc. | 2014-07-01 |
| A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults (NCT02201849) | Biogen | 2014-07-01 |
| Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers (NCT02183675) | Boehringer Ingelheim | 2014-07-01 |
| A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer (NCT02207465) | Abramson Cancer Center at Penn Medicine | 2014-07-01 |
| A Trial of MBC-11 in Patients With CIBD (NCT02673060) | Osteros Biomedica Ltd | 2014-07-01 |
| Bioequivalence of Liquid and Reconstituted Lyophilized Subcutaneous Formulations of Caplacizumab. (NCT02189733) | Ablynx, a Sanofi company | 2014-07-01 |
| Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy (NCT02414776) | Western Regional Medical Center | 2014-07-01 |
| Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization (NCT02118987) | Dana-Farber Cancer Institute | 2014-07-01 |
| Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer (NCT02252796) | West Virginia University | 2014-07-01 |
| Mesenchymal Stem Cell Therapy for Lung Rejection (NCT02181712) | Mayo Clinic | 2014-07-01 |
| Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management (NCT02199236) | Memorial Sloan Kettering Cancer Center | 2014-07-01 |
| Adoptive Transfer of Haplo-identical DLI for AML and MDS (NCT02046122) | Duke University | 2014-07-01 |
| Merging Yoga and Group OT (MY-OT) to Improve Balance and Decrease Fall Risk After Stroke (NCT02933515) | Colorado State University | 2014-07-01 |
| Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer (NCT02194049) | University of California, Davis | 2014-07-01 |
| Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT) (NCT01827579) | University College, London | 2014-07-01 |
| Hyaluronidase Effect on Infusion Set Life (NCT02199028) | Stanford University | 2014-07-01 |
| CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children (NCT02204917) | Kassa Darge | 2014-07-01 |
| Safety of BBB Opening With the SonoCloud (NCT02253212) | Assistance Publique - Hôpitaux de Paris | 2014-07-01 |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (NCT02260544) | Dr. Reddy's Laboratories Limited | 2014-07-01 |
| Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation (NCT02328885) | Banc de Sang i Teixits | 2014-07-01 |
| Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus (NCT02123732) | Laniado Hospital | 2014-07-01 |
| Investigate Absorption, Metabolism, Excretion, and Mass Balance of Pacritinib (NCT02803762) | CTI BioPharma | 2014-07-01 |
| Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy (NCT02205372) | Tanabe Pharma Corporation | 2014-07-01 |
| Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers (NCT02160158) | Pfizer | 2014-07-01 |
| IL-32 Levels in Patients With Chronic Periodontitis (NCT02632981) | Bulent Ecevit University | 2014-07-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 Days (NCT02140320) | Respivert Ltd | 2014-07-01 |
| A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649 (NCT02170012) | Pfizer | 2014-07-01 |
| A Single Ascending Dose Escalation to Investigate Safety and PK of VVZ-149 Injection in Healthy Older Male Volunteers (NCT02333318) | Vivozon, Inc. | 2014-07-01 |
| Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours (NCT02181075) | University of Oxford | 2014-07-01 |
| Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma (NCT02192736) | Translational Biosciences | 2014-07-01 |
| [14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study (NCT02373176) | Pronova BioPharma | 2014-07-01 |
| Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults (NCT02207920) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-07-01 |
| A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects (NCT02256423) | Simbec Research | 2014-07-01 |
| Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease (NCT02199561) | University of Alberta | 2014-07-01 |
| PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects (NCT02130414) | Sigmoid Pharma | 2014-07-01 |
| Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers (NCT02183545) | Boehringer Ingelheim | 2014-07-01 |
| Study to Evaluate the Effect of a Known and Marketed Product, Itraconazole (Mycosis Treatment) on Lu AF11167 Entering the Body and Subsequently Elimination. The Study is a Drug-drug Interaction Study in Healthy Volunteers. (NCT02199431) | H. Lundbeck A/S | 2014-07-01 |
| S-Equol in Alzheimer's Disease (SEAD) Trial (NCT02142777) | Russell Swerdlow, MD | 2014-07-01 |
| Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma (NCT02141100) | Kjeld Schmiegelow | 2014-07-01 |
| Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935 (NCT02201056) | Takeda | 2014-07-01 |
| NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (NCT02059850) | Fred Hutchinson Cancer Center | 2014-07-01 |